Evidence map›Paper›PMID 39885682›Full record

ReviewThe American journal of case reports2025

Rhabdomyolysis of Infectious Etiology with Creatine Kinase Above One Million: A Case Report.

Marshall Weber, William Goss, Colton Hoffer, Joseph Ogunsulire, Ferdinand Schafer

Abstract readCase ReportsReview
In one paragraph

Review in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marshall WeberDepartment of Internal Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
William GossDepartment of Internal Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Colton HofferCharlie Norwood Veterans Affairs Medical Center, Augusta, GA, USA.
Joseph OgunsulireDivision of Nephrology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Ferdinand SchaferDepartment of Internal Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Rhabdomyolysis occurs commonly in hospitalized patients due to many etiologies. It is characterized by elevated creatine kinase, weakness, and myalgias, with severe forms causing electrolyte imbalances. However, many of these patients have a mild disease course with no symptoms. Those with more severe disease often have associated acute kidney injury. When acute kidney injury occurs solely due to rhabdomyolysis, it is unlikely to cause the patient to require renal replacement therapy. Regardless of how common this disease is, little research has been done to determine prognosticating factors for renal recovery in the patients who do require renal replacement therapy. CASE REPORT We present the case a young patient who developed severe kidney damage from rhabdomyolysis, requiring renal replacement, and who had renal recovery in a relatively short time. Our patient's maximum creatine kinase was 1 353 105 IU/L. Yet regardless of this severe elevation, his kidneys showed full recovery in under 3 weeks. CONCLUSIONS We present a case of a patient with rhabdomyolysis and CK above one million. In our literature review, we found that exertion and genetic defects were found to cause CK elevations above one hundred thousand, but infection is perhaps the most common cause of such extreme elevations. Regardless of how high CK is, there are no consistent factors reported in the literature correlating with degree of and rate of renal recovery in these patients.

Indexed as

Acute Kidney InjuryCreatine KinaseRhabdomyolysisHumansMaleRenal Replacement TherapyCreatine Kinase

Identifiers

PMID39885682
PMCPMC11791690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.